Medical Care
Global Inhalational Anaesthesia Drugs Market Research Report 2025
- Jul 08, 25
- ID: 347526
- Pages: 80
- Figures: 77
- Views: 2
The global market for Inhalational Anaesthesia Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Inhalational anaesthesia drugs, ether and halothane were more commonly used in the past, and sevoflurane, desflurane, and isoflurane are more commonly used. Inhaled anesthetics can enter the lungs through the patient"s respiratory tract, diffuse into the capillaries, and then enter the body"s circulatory system and central nervous system. For inhalational anaesthesia drugs, professional equipment should be used. The patient can make the pain and consciousness disappear within a few minutes after the inhalation anesthesia, so that the operation can proceed smoothly. After stopping the medication, the patient can quickly regain self-awareness. Inhaled anesthetics are characterized by strong controllability and high safety, and they are a common method of anesthesia used in clinical practice.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Inhalational Anaesthesia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalational Anaesthesia Drugs.
The Inhalational Anaesthesia Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inhalational Anaesthesia Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhalational Anaesthesia Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie Inc.
Baxter
Hikma Pharmaceuticals PLC
Halocarbon Products Corporation
Piramal Enterprises Limited
Lunan Pharmaceutical Group Co. Ltd.
Segment by Type
Enflurane
Isoflurane
Halothane
Sevoflurane
Atropine
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inhalational Anaesthesia Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Inhalational anaesthesia drugs, ether and halothane were more commonly used in the past, and sevoflurane, desflurane, and isoflurane are more commonly used. Inhaled anesthetics can enter the lungs through the patient"s respiratory tract, diffuse into the capillaries, and then enter the body"s circulatory system and central nervous system. For inhalational anaesthesia drugs, professional equipment should be used. The patient can make the pain and consciousness disappear within a few minutes after the inhalation anesthesia, so that the operation can proceed smoothly. After stopping the medication, the patient can quickly regain self-awareness. Inhaled anesthetics are characterized by strong controllability and high safety, and they are a common method of anesthesia used in clinical practice.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Inhalational Anaesthesia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalational Anaesthesia Drugs.
The Inhalational Anaesthesia Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inhalational Anaesthesia Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhalational Anaesthesia Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie Inc.
Baxter
Hikma Pharmaceuticals PLC
Halocarbon Products Corporation
Piramal Enterprises Limited
Lunan Pharmaceutical Group Co. Ltd.
Segment by Type
Enflurane
Isoflurane
Halothane
Sevoflurane
Atropine
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inhalational Anaesthesia Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inhalational Anaesthesia Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Enflurane
1.2.3 Isoflurane
1.2.4 Halothane
1.2.5 Sevoflurane
1.2.6 Atropine
1.3 Market by Application
1.3.1 Global Inhalational Anaesthesia Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Inhalational Anaesthesia Drugs Market Perspective (2020-2031)
2.2 Global Inhalational Anaesthesia Drugs Growth Trends by Region
2.2.1 Global Inhalational Anaesthesia Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Inhalational Anaesthesia Drugs Historic Market Size by Region (2020-2025)
2.2.3 Inhalational Anaesthesia Drugs Forecasted Market Size by Region (2026-2031)
2.3 Inhalational Anaesthesia Drugs Market Dynamics
2.3.1 Inhalational Anaesthesia Drugs Industry Trends
2.3.2 Inhalational Anaesthesia Drugs Market Drivers
2.3.3 Inhalational Anaesthesia Drugs Market Challenges
2.3.4 Inhalational Anaesthesia Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inhalational Anaesthesia Drugs Players by Revenue
3.1.1 Global Top Inhalational Anaesthesia Drugs Players by Revenue (2020-2025)
3.1.2 Global Inhalational Anaesthesia Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Inhalational Anaesthesia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Inhalational Anaesthesia Drugs Revenue
3.4 Global Inhalational Anaesthesia Drugs Market Concentration Ratio
3.4.1 Global Inhalational Anaesthesia Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inhalational Anaesthesia Drugs Revenue in 2024
3.5 Global Key Players of Inhalational Anaesthesia Drugs Head office and Area Served
3.6 Global Key Players of Inhalational Anaesthesia Drugs, Product and Application
3.7 Global Key Players of Inhalational Anaesthesia Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Inhalational Anaesthesia Drugs Breakdown Data by Type
4.1 Global Inhalational Anaesthesia Drugs Historic Market Size by Type (2020-2025)
4.2 Global Inhalational Anaesthesia Drugs Forecasted Market Size by Type (2026-2031)
5 Inhalational Anaesthesia Drugs Breakdown Data by Application
5.1 Global Inhalational Anaesthesia Drugs Historic Market Size by Application (2020-2025)
5.2 Global Inhalational Anaesthesia Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Inhalational Anaesthesia Drugs Market Size (2020-2031)
6.2 North America Inhalational Anaesthesia Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Inhalational Anaesthesia Drugs Market Size by Country (2020-2025)
6.4 North America Inhalational Anaesthesia Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Inhalational Anaesthesia Drugs Market Size (2020-2031)
7.2 Europe Inhalational Anaesthesia Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Inhalational Anaesthesia Drugs Market Size by Country (2020-2025)
7.4 Europe Inhalational Anaesthesia Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Inhalational Anaesthesia Drugs Market Size (2020-2031)
8.2 Asia-Pacific Inhalational Anaesthesia Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Inhalational Anaesthesia Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Inhalational Anaesthesia Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Inhalational Anaesthesia Drugs Market Size (2020-2031)
9.2 Latin America Inhalational Anaesthesia Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Inhalational Anaesthesia Drugs Market Size by Country (2020-2025)
9.4 Latin America Inhalational Anaesthesia Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inhalational Anaesthesia Drugs Market Size (2020-2031)
10.2 Middle East & Africa Inhalational Anaesthesia Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Inhalational Anaesthesia Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Inhalational Anaesthesia Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Company Details
11.1.2 AbbVie Inc. Business Overview
11.1.3 AbbVie Inc. Inhalational Anaesthesia Drugs Introduction
11.1.4 AbbVie Inc. Revenue in Inhalational Anaesthesia Drugs Business (2020-2025)
11.1.5 AbbVie Inc. Recent Development
11.2 Baxter
11.2.1 Baxter Company Details
11.2.2 Baxter Business Overview
11.2.3 Baxter Inhalational Anaesthesia Drugs Introduction
11.2.4 Baxter Revenue in Inhalational Anaesthesia Drugs Business (2020-2025)
11.2.5 Baxter Recent Development
11.3 Hikma Pharmaceuticals PLC
11.3.1 Hikma Pharmaceuticals PLC Company Details
11.3.2 Hikma Pharmaceuticals PLC Business Overview
11.3.3 Hikma Pharmaceuticals PLC Inhalational Anaesthesia Drugs Introduction
11.3.4 Hikma Pharmaceuticals PLC Revenue in Inhalational Anaesthesia Drugs Business (2020-2025)
11.3.5 Hikma Pharmaceuticals PLC Recent Development
11.4 Halocarbon Products Corporation
11.4.1 Halocarbon Products Corporation Company Details
11.4.2 Halocarbon Products Corporation Business Overview
11.4.3 Halocarbon Products Corporation Inhalational Anaesthesia Drugs Introduction
11.4.4 Halocarbon Products Corporation Revenue in Inhalational Anaesthesia Drugs Business (2020-2025)
11.4.5 Halocarbon Products Corporation Recent Development
11.5 Piramal Enterprises Limited
11.5.1 Piramal Enterprises Limited Company Details
11.5.2 Piramal Enterprises Limited Business Overview
11.5.3 Piramal Enterprises Limited Inhalational Anaesthesia Drugs Introduction
11.5.4 Piramal Enterprises Limited Revenue in Inhalational Anaesthesia Drugs Business (2020-2025)
11.5.5 Piramal Enterprises Limited Recent Development
11.6 Lunan Pharmaceutical Group Co. Ltd.
11.6.1 Lunan Pharmaceutical Group Co. Ltd. Company Details
11.6.2 Lunan Pharmaceutical Group Co. Ltd. Business Overview
11.6.3 Lunan Pharmaceutical Group Co. Ltd. Inhalational Anaesthesia Drugs Introduction
11.6.4 Lunan Pharmaceutical Group Co. Ltd. Revenue in Inhalational Anaesthesia Drugs Business (2020-2025)
11.6.5 Lunan Pharmaceutical Group Co. Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inhalational Anaesthesia Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Enflurane
1.2.3 Isoflurane
1.2.4 Halothane
1.2.5 Sevoflurane
1.2.6 Atropine
1.3 Market by Application
1.3.1 Global Inhalational Anaesthesia Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Inhalational Anaesthesia Drugs Market Perspective (2020-2031)
2.2 Global Inhalational Anaesthesia Drugs Growth Trends by Region
2.2.1 Global Inhalational Anaesthesia Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Inhalational Anaesthesia Drugs Historic Market Size by Region (2020-2025)
2.2.3 Inhalational Anaesthesia Drugs Forecasted Market Size by Region (2026-2031)
2.3 Inhalational Anaesthesia Drugs Market Dynamics
2.3.1 Inhalational Anaesthesia Drugs Industry Trends
2.3.2 Inhalational Anaesthesia Drugs Market Drivers
2.3.3 Inhalational Anaesthesia Drugs Market Challenges
2.3.4 Inhalational Anaesthesia Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inhalational Anaesthesia Drugs Players by Revenue
3.1.1 Global Top Inhalational Anaesthesia Drugs Players by Revenue (2020-2025)
3.1.2 Global Inhalational Anaesthesia Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Inhalational Anaesthesia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Inhalational Anaesthesia Drugs Revenue
3.4 Global Inhalational Anaesthesia Drugs Market Concentration Ratio
3.4.1 Global Inhalational Anaesthesia Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inhalational Anaesthesia Drugs Revenue in 2024
3.5 Global Key Players of Inhalational Anaesthesia Drugs Head office and Area Served
3.6 Global Key Players of Inhalational Anaesthesia Drugs, Product and Application
3.7 Global Key Players of Inhalational Anaesthesia Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Inhalational Anaesthesia Drugs Breakdown Data by Type
4.1 Global Inhalational Anaesthesia Drugs Historic Market Size by Type (2020-2025)
4.2 Global Inhalational Anaesthesia Drugs Forecasted Market Size by Type (2026-2031)
5 Inhalational Anaesthesia Drugs Breakdown Data by Application
5.1 Global Inhalational Anaesthesia Drugs Historic Market Size by Application (2020-2025)
5.2 Global Inhalational Anaesthesia Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Inhalational Anaesthesia Drugs Market Size (2020-2031)
6.2 North America Inhalational Anaesthesia Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Inhalational Anaesthesia Drugs Market Size by Country (2020-2025)
6.4 North America Inhalational Anaesthesia Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Inhalational Anaesthesia Drugs Market Size (2020-2031)
7.2 Europe Inhalational Anaesthesia Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Inhalational Anaesthesia Drugs Market Size by Country (2020-2025)
7.4 Europe Inhalational Anaesthesia Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Inhalational Anaesthesia Drugs Market Size (2020-2031)
8.2 Asia-Pacific Inhalational Anaesthesia Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Inhalational Anaesthesia Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Inhalational Anaesthesia Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Inhalational Anaesthesia Drugs Market Size (2020-2031)
9.2 Latin America Inhalational Anaesthesia Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Inhalational Anaesthesia Drugs Market Size by Country (2020-2025)
9.4 Latin America Inhalational Anaesthesia Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inhalational Anaesthesia Drugs Market Size (2020-2031)
10.2 Middle East & Africa Inhalational Anaesthesia Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Inhalational Anaesthesia Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Inhalational Anaesthesia Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Company Details
11.1.2 AbbVie Inc. Business Overview
11.1.3 AbbVie Inc. Inhalational Anaesthesia Drugs Introduction
11.1.4 AbbVie Inc. Revenue in Inhalational Anaesthesia Drugs Business (2020-2025)
11.1.5 AbbVie Inc. Recent Development
11.2 Baxter
11.2.1 Baxter Company Details
11.2.2 Baxter Business Overview
11.2.3 Baxter Inhalational Anaesthesia Drugs Introduction
11.2.4 Baxter Revenue in Inhalational Anaesthesia Drugs Business (2020-2025)
11.2.5 Baxter Recent Development
11.3 Hikma Pharmaceuticals PLC
11.3.1 Hikma Pharmaceuticals PLC Company Details
11.3.2 Hikma Pharmaceuticals PLC Business Overview
11.3.3 Hikma Pharmaceuticals PLC Inhalational Anaesthesia Drugs Introduction
11.3.4 Hikma Pharmaceuticals PLC Revenue in Inhalational Anaesthesia Drugs Business (2020-2025)
11.3.5 Hikma Pharmaceuticals PLC Recent Development
11.4 Halocarbon Products Corporation
11.4.1 Halocarbon Products Corporation Company Details
11.4.2 Halocarbon Products Corporation Business Overview
11.4.3 Halocarbon Products Corporation Inhalational Anaesthesia Drugs Introduction
11.4.4 Halocarbon Products Corporation Revenue in Inhalational Anaesthesia Drugs Business (2020-2025)
11.4.5 Halocarbon Products Corporation Recent Development
11.5 Piramal Enterprises Limited
11.5.1 Piramal Enterprises Limited Company Details
11.5.2 Piramal Enterprises Limited Business Overview
11.5.3 Piramal Enterprises Limited Inhalational Anaesthesia Drugs Introduction
11.5.4 Piramal Enterprises Limited Revenue in Inhalational Anaesthesia Drugs Business (2020-2025)
11.5.5 Piramal Enterprises Limited Recent Development
11.6 Lunan Pharmaceutical Group Co. Ltd.
11.6.1 Lunan Pharmaceutical Group Co. Ltd. Company Details
11.6.2 Lunan Pharmaceutical Group Co. Ltd. Business Overview
11.6.3 Lunan Pharmaceutical Group Co. Ltd. Inhalational Anaesthesia Drugs Introduction
11.6.4 Lunan Pharmaceutical Group Co. Ltd. Revenue in Inhalational Anaesthesia Drugs Business (2020-2025)
11.6.5 Lunan Pharmaceutical Group Co. Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Inhalational Anaesthesia Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Enflurane
Table 3. Key Players of Isoflurane
Table 4. Key Players of Halothane
Table 5. Key Players of Sevoflurane
Table 6. Key Players of Atropine
Table 7. Global Inhalational Anaesthesia Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Inhalational Anaesthesia Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Inhalational Anaesthesia Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Inhalational Anaesthesia Drugs Market Share by Region (2020-2025)
Table 11. Global Inhalational Anaesthesia Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Inhalational Anaesthesia Drugs Market Share by Region (2026-2031)
Table 13. Inhalational Anaesthesia Drugs Market Trends
Table 14. Inhalational Anaesthesia Drugs Market Drivers
Table 15. Inhalational Anaesthesia Drugs Market Challenges
Table 16. Inhalational Anaesthesia Drugs Market Restraints
Table 17. Global Inhalational Anaesthesia Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Inhalational Anaesthesia Drugs Market Share by Players (2020-2025)
Table 19. Global Top Inhalational Anaesthesia Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalational Anaesthesia Drugs as of 2024)
Table 20. Ranking of Global Top Inhalational Anaesthesia Drugs Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Inhalational Anaesthesia Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Inhalational Anaesthesia Drugs, Headquarters and Area Served
Table 23. Global Key Players of Inhalational Anaesthesia Drugs, Product and Application
Table 24. Global Key Players of Inhalational Anaesthesia Drugs, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Inhalational Anaesthesia Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Inhalational Anaesthesia Drugs Revenue Market Share by Type (2020-2025)
Table 28. Global Inhalational Anaesthesia Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Inhalational Anaesthesia Drugs Revenue Market Share by Type (2026-2031)
Table 30. Global Inhalational Anaesthesia Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Inhalational Anaesthesia Drugs Revenue Market Share by Application (2020-2025)
Table 32. Global Inhalational Anaesthesia Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Inhalational Anaesthesia Drugs Revenue Market Share by Application (2026-2031)
Table 34. North America Inhalational Anaesthesia Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Inhalational Anaesthesia Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Inhalational Anaesthesia Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Inhalational Anaesthesia Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Inhalational Anaesthesia Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Inhalational Anaesthesia Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Inhalational Anaesthesia Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Inhalational Anaesthesia Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Inhalational Anaesthesia Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Inhalational Anaesthesia Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Inhalational Anaesthesia Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Inhalational Anaesthesia Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Inhalational Anaesthesia Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Inhalational Anaesthesia Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Inhalational Anaesthesia Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 49. AbbVie Inc. Company Details
Table 50. AbbVie Inc. Business Overview
Table 51. AbbVie Inc. Inhalational Anaesthesia Drugs Product
Table 52. AbbVie Inc. Revenue in Inhalational Anaesthesia Drugs Business (2020-2025) & (US$ Million)
Table 53. AbbVie Inc. Recent Development
Table 54. Baxter Company Details
Table 55. Baxter Business Overview
Table 56. Baxter Inhalational Anaesthesia Drugs Product
Table 57. Baxter Revenue in Inhalational Anaesthesia Drugs Business (2020-2025) & (US$ Million)
Table 58. Baxter Recent Development
Table 59. Hikma Pharmaceuticals PLC Company Details
Table 60. Hikma Pharmaceuticals PLC Business Overview
Table 61. Hikma Pharmaceuticals PLC Inhalational Anaesthesia Drugs Product
Table 62. Hikma Pharmaceuticals PLC Revenue in Inhalational Anaesthesia Drugs Business (2020-2025) & (US$ Million)
Table 63. Hikma Pharmaceuticals PLC Recent Development
Table 64. Halocarbon Products Corporation Company Details
Table 65. Halocarbon Products Corporation Business Overview
Table 66. Halocarbon Products Corporation Inhalational Anaesthesia Drugs Product
Table 67. Halocarbon Products Corporation Revenue in Inhalational Anaesthesia Drugs Business (2020-2025) & (US$ Million)
Table 68. Halocarbon Products Corporation Recent Development
Table 69. Piramal Enterprises Limited Company Details
Table 70. Piramal Enterprises Limited Business Overview
Table 71. Piramal Enterprises Limited Inhalational Anaesthesia Drugs Product
Table 72. Piramal Enterprises Limited Revenue in Inhalational Anaesthesia Drugs Business (2020-2025) & (US$ Million)
Table 73. Piramal Enterprises Limited Recent Development
Table 74. Lunan Pharmaceutical Group Co. Ltd. Company Details
Table 75. Lunan Pharmaceutical Group Co. Ltd. Business Overview
Table 76. Lunan Pharmaceutical Group Co. Ltd. Inhalational Anaesthesia Drugs Product
Table 77. Lunan Pharmaceutical Group Co. Ltd. Revenue in Inhalational Anaesthesia Drugs Business (2020-2025) & (US$ Million)
Table 78. Lunan Pharmaceutical Group Co. Ltd. Recent Development
Table 79. Research Programs/Design for This Report
Table 80. Key Data Information from Secondary Sources
Table 81. Key Data Information from Primary Sources
Table 82. Authors List of This Report
List of Figures
Figure 1. Inhalational Anaesthesia Drugs Picture
Figure 2. Global Inhalational Anaesthesia Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Inhalational Anaesthesia Drugs Market Share by Type: 2024 VS 2031
Figure 4. Enflurane Features
Figure 5. Isoflurane Features
Figure 6. Halothane Features
Figure 7. Sevoflurane Features
Figure 8. Atropine Features
Figure 9. Global Inhalational Anaesthesia Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Inhalational Anaesthesia Drugs Market Share by Application: 2024 VS 2031
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Retail Pharmacies Case Studies
Figure 14. Inhalational Anaesthesia Drugs Report Years Considered
Figure 15. Global Inhalational Anaesthesia Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Inhalational Anaesthesia Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Inhalational Anaesthesia Drugs Market Share by Region: 2024 VS 2031
Figure 18. Global Inhalational Anaesthesia Drugs Market Share by Players in 2024
Figure 19. Global Top Inhalational Anaesthesia Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalational Anaesthesia Drugs as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Inhalational Anaesthesia Drugs Revenue in 2024
Figure 21. North America Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Inhalational Anaesthesia Drugs Market Share by Country (2020-2031)
Figure 23. United States Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Inhalational Anaesthesia Drugs Market Share by Country (2020-2031)
Figure 27. Germany Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Inhalational Anaesthesia Drugs Market Share by Region (2020-2031)
Figure 35. China Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Inhalational Anaesthesia Drugs Market Share by Country (2020-2031)
Figure 43. Mexico Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Inhalational Anaesthesia Drugs Market Share by Country (2020-2031)
Figure 47. Turkey Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. AbbVie Inc. Revenue Growth Rate in Inhalational Anaesthesia Drugs Business (2020-2025)
Figure 51. Baxter Revenue Growth Rate in Inhalational Anaesthesia Drugs Business (2020-2025)
Figure 52. Hikma Pharmaceuticals PLC Revenue Growth Rate in Inhalational Anaesthesia Drugs Business (2020-2025)
Figure 53. Halocarbon Products Corporation Revenue Growth Rate in Inhalational Anaesthesia Drugs Business (2020-2025)
Figure 54. Piramal Enterprises Limited Revenue Growth Rate in Inhalational Anaesthesia Drugs Business (2020-2025)
Figure 55. Lunan Pharmaceutical Group Co. Ltd. Revenue Growth Rate in Inhalational Anaesthesia Drugs Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Inhalational Anaesthesia Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Enflurane
Table 3. Key Players of Isoflurane
Table 4. Key Players of Halothane
Table 5. Key Players of Sevoflurane
Table 6. Key Players of Atropine
Table 7. Global Inhalational Anaesthesia Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Inhalational Anaesthesia Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Inhalational Anaesthesia Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Inhalational Anaesthesia Drugs Market Share by Region (2020-2025)
Table 11. Global Inhalational Anaesthesia Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Inhalational Anaesthesia Drugs Market Share by Region (2026-2031)
Table 13. Inhalational Anaesthesia Drugs Market Trends
Table 14. Inhalational Anaesthesia Drugs Market Drivers
Table 15. Inhalational Anaesthesia Drugs Market Challenges
Table 16. Inhalational Anaesthesia Drugs Market Restraints
Table 17. Global Inhalational Anaesthesia Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Inhalational Anaesthesia Drugs Market Share by Players (2020-2025)
Table 19. Global Top Inhalational Anaesthesia Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalational Anaesthesia Drugs as of 2024)
Table 20. Ranking of Global Top Inhalational Anaesthesia Drugs Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Inhalational Anaesthesia Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Inhalational Anaesthesia Drugs, Headquarters and Area Served
Table 23. Global Key Players of Inhalational Anaesthesia Drugs, Product and Application
Table 24. Global Key Players of Inhalational Anaesthesia Drugs, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Inhalational Anaesthesia Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Inhalational Anaesthesia Drugs Revenue Market Share by Type (2020-2025)
Table 28. Global Inhalational Anaesthesia Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Inhalational Anaesthesia Drugs Revenue Market Share by Type (2026-2031)
Table 30. Global Inhalational Anaesthesia Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Inhalational Anaesthesia Drugs Revenue Market Share by Application (2020-2025)
Table 32. Global Inhalational Anaesthesia Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Inhalational Anaesthesia Drugs Revenue Market Share by Application (2026-2031)
Table 34. North America Inhalational Anaesthesia Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Inhalational Anaesthesia Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Inhalational Anaesthesia Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Inhalational Anaesthesia Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Inhalational Anaesthesia Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Inhalational Anaesthesia Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Inhalational Anaesthesia Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Inhalational Anaesthesia Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Inhalational Anaesthesia Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Inhalational Anaesthesia Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Inhalational Anaesthesia Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Inhalational Anaesthesia Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Inhalational Anaesthesia Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Inhalational Anaesthesia Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Inhalational Anaesthesia Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 49. AbbVie Inc. Company Details
Table 50. AbbVie Inc. Business Overview
Table 51. AbbVie Inc. Inhalational Anaesthesia Drugs Product
Table 52. AbbVie Inc. Revenue in Inhalational Anaesthesia Drugs Business (2020-2025) & (US$ Million)
Table 53. AbbVie Inc. Recent Development
Table 54. Baxter Company Details
Table 55. Baxter Business Overview
Table 56. Baxter Inhalational Anaesthesia Drugs Product
Table 57. Baxter Revenue in Inhalational Anaesthesia Drugs Business (2020-2025) & (US$ Million)
Table 58. Baxter Recent Development
Table 59. Hikma Pharmaceuticals PLC Company Details
Table 60. Hikma Pharmaceuticals PLC Business Overview
Table 61. Hikma Pharmaceuticals PLC Inhalational Anaesthesia Drugs Product
Table 62. Hikma Pharmaceuticals PLC Revenue in Inhalational Anaesthesia Drugs Business (2020-2025) & (US$ Million)
Table 63. Hikma Pharmaceuticals PLC Recent Development
Table 64. Halocarbon Products Corporation Company Details
Table 65. Halocarbon Products Corporation Business Overview
Table 66. Halocarbon Products Corporation Inhalational Anaesthesia Drugs Product
Table 67. Halocarbon Products Corporation Revenue in Inhalational Anaesthesia Drugs Business (2020-2025) & (US$ Million)
Table 68. Halocarbon Products Corporation Recent Development
Table 69. Piramal Enterprises Limited Company Details
Table 70. Piramal Enterprises Limited Business Overview
Table 71. Piramal Enterprises Limited Inhalational Anaesthesia Drugs Product
Table 72. Piramal Enterprises Limited Revenue in Inhalational Anaesthesia Drugs Business (2020-2025) & (US$ Million)
Table 73. Piramal Enterprises Limited Recent Development
Table 74. Lunan Pharmaceutical Group Co. Ltd. Company Details
Table 75. Lunan Pharmaceutical Group Co. Ltd. Business Overview
Table 76. Lunan Pharmaceutical Group Co. Ltd. Inhalational Anaesthesia Drugs Product
Table 77. Lunan Pharmaceutical Group Co. Ltd. Revenue in Inhalational Anaesthesia Drugs Business (2020-2025) & (US$ Million)
Table 78. Lunan Pharmaceutical Group Co. Ltd. Recent Development
Table 79. Research Programs/Design for This Report
Table 80. Key Data Information from Secondary Sources
Table 81. Key Data Information from Primary Sources
Table 82. Authors List of This Report
List of Figures
Figure 1. Inhalational Anaesthesia Drugs Picture
Figure 2. Global Inhalational Anaesthesia Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Inhalational Anaesthesia Drugs Market Share by Type: 2024 VS 2031
Figure 4. Enflurane Features
Figure 5. Isoflurane Features
Figure 6. Halothane Features
Figure 7. Sevoflurane Features
Figure 8. Atropine Features
Figure 9. Global Inhalational Anaesthesia Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Inhalational Anaesthesia Drugs Market Share by Application: 2024 VS 2031
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Retail Pharmacies Case Studies
Figure 14. Inhalational Anaesthesia Drugs Report Years Considered
Figure 15. Global Inhalational Anaesthesia Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Inhalational Anaesthesia Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Inhalational Anaesthesia Drugs Market Share by Region: 2024 VS 2031
Figure 18. Global Inhalational Anaesthesia Drugs Market Share by Players in 2024
Figure 19. Global Top Inhalational Anaesthesia Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalational Anaesthesia Drugs as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Inhalational Anaesthesia Drugs Revenue in 2024
Figure 21. North America Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Inhalational Anaesthesia Drugs Market Share by Country (2020-2031)
Figure 23. United States Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Inhalational Anaesthesia Drugs Market Share by Country (2020-2031)
Figure 27. Germany Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Inhalational Anaesthesia Drugs Market Share by Region (2020-2031)
Figure 35. China Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Inhalational Anaesthesia Drugs Market Share by Country (2020-2031)
Figure 43. Mexico Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Inhalational Anaesthesia Drugs Market Share by Country (2020-2031)
Figure 47. Turkey Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Inhalational Anaesthesia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. AbbVie Inc. Revenue Growth Rate in Inhalational Anaesthesia Drugs Business (2020-2025)
Figure 51. Baxter Revenue Growth Rate in Inhalational Anaesthesia Drugs Business (2020-2025)
Figure 52. Hikma Pharmaceuticals PLC Revenue Growth Rate in Inhalational Anaesthesia Drugs Business (2020-2025)
Figure 53. Halocarbon Products Corporation Revenue Growth Rate in Inhalational Anaesthesia Drugs Business (2020-2025)
Figure 54. Piramal Enterprises Limited Revenue Growth Rate in Inhalational Anaesthesia Drugs Business (2020-2025)
Figure 55. Lunan Pharmaceutical Group Co. Ltd. Revenue Growth Rate in Inhalational Anaesthesia Drugs Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232